Abstract
Background: Hydrazones, one of the important classes of organic molecules, are pharmaceutical agents comprising –CO-NH-N=CH- group in the structure therefore and exhibiting significant biological activity.
Methods: 5-Chloro-N’-[(substituted)methylidene] pyrazine-2-carbohydrazide (3a-g) and their Pd(II) complexes (4a-h) were synthesized and investigated in vitro anticancer activity on A549, Caco2 cancer and normal 3T3 fibroblast cell lines, using the MTT assay.
Results: Anticancer activity screening results revealed that some compounds showed remarkable cytotoxic effect. Among them, 5-chloro-N'-[(4-hydroxyphenyl)methylidene] pyrazine-2-carbohydrazide (3c) displayed higher cytotoxic activity against A549 cancer cell line than the reference drug cisplatin.
Conclusion: Compound 3c showed high cytotoxic activity against A549 cancer cell line but it showed low cytotoxic effect against normal 3T3 fibroblast cell line. Antiproliferative and antimetastatic effects of 3c were determined by the real-time monitoring of cell proliferative system (RTCA DP). The cell proliferation, metastatic and invasive activities of A549 cells were decreased due to increased concentration of 3c.
Keywords: Hydrazone, metal-complexes, anticancer activity, MTT assay, real-time monitoring, proliferative system.
Graphical Abstract
[1]
Lou, J.; Liu, Z.; Li, Y.; Zhou, M.; Zhang, Z.; Zheng, S.; Wang, R.; Li, J. Synthesis and anti-tumor activities of N′-benzylidene-2-(4-oxothieno[2,3-d]pyrimidin-3(4H)-yl) acetohydrazone derivatives. Bioorg. Med. Chem. Lett., 2011, 21, 6662-6666.
[2]
Kumar, D.; Kumar, N.M.; Ghosh, S.; Shah, K. Novel bis(indolyl)hydrazide-hydrazones as potent cytotoxic agents. Bioorg. Med. Chem. Lett., 2012, 22, 212-215.
[3]
Dandawate, P.; Khan, E.; Padhye, S.; Gaba, H.; Sinha, S.; Deshpande, J.; Swamy, K.V.; Khetmalas, M.; Ahmad, A.; Sarkar, F.H. Synthesis, characterization, molecular docking and cytotoxic activity of novel plumbagin hydrazones against breast cancer cells. Bioorg. Med. Chem. Lett., 2012, 22, 3104-3108.
[4]
Islam, R.; Koizumi, F.; Kodera, Y.; Inoue, K.; Okawara, T.; Masutanid, M. Design and synthesis of phenolic hydrazide hydrazones as potent poly(ADP-ribose) glycohydrolase (PARG) inhibitors. Bioorg. Med. Chem. Lett., 2014, 24, 3802-3806.
[5]
Wei-Yong, L.; Hai-Ying, L.; Bao-Xiang, Z.; Dong-Soo, S.; Song, L.; Jun-Ying, M. Synthesis of novel ribavirin hydrazone derivatives and anti-proliferative activity against A549 lung cancer cells. Carbohydr. Res., 2009, 344, 1270-1275.
[6]
Altıntop, M.D.; Özdemir, A.; Turan-Zitouni, G.; Ilgın, S.; Atlı, Ö.; Işcan, G.; Kaplancıklı, Z.A. Synthesis and biological evaluation of some hydrazone derivatives as new anticandidal and anticancer agents. Eur. J. Med. Chem., 2012, 58, 299-307.
[7]
Nasr, T.; Bondock, S.; Youns, M. Anticancer activity of new coumarin substituted hydrazide-hydrazone derivatives. Eur. J. Med. Chem., 2014, 76, 539-548.
[8]
Congiu, C.; Onnis, V. Synthesis and biological evaluation of novel acylhydrazone derivatives as potential antitumor agents. Bioorg. Med. Chem. Lett., 2013, 20, 6592-6599.
[9]
Mishraa, M.; Tiwari, K.; Shukla, S.; Mishra, R.; Singh, V.P. Synthesis, structural investigation, DNA and protein binding study of some 3D-metal complexes with N′-(phenyl-pyridin-2-yl-methylene)-thiophene-2-carboxylic acid hydrazide. Spectrochim. Acta Part A Mol. Biomol. Spectrosc., 2014, 132, 452-464.
[10]
Chitrapriyaa, N.; Kamatchi, T.S.; Zeller, M.; Leea, H.; Natarajan, K. Synthesis, spectroscopic, crystal structure and DNA binding of Ru (II) complexes with 2-hydroxy-benzoic acid [1-(4-hydroxy-6-methyl-2-oxo-2H-pyran-3-yl)-ethylidene]-hydrazide. Spectrochim. Acta Part A Mol. Biomol. Spectrosc., 2011, 81, 128-134.
[11]
El-Morsy, F.A.; Jean-Claude, B.J.; Butler, I.S.; El-Sayed, S.A.; Mostafa, S.I. Synthesis, characterization and anticancer activity of new zinc(II), molybdate(II), palladium(II), silver(I), rhodium(III), ruthenium(II) and platinum(II) complexes of 5,6-diamino-4-hydroxy-2-mercaptopyrimidine. Inorg. Chim. Acta, 2014, 423, 144-155.
[12]
Mahalingam, V.; Chitrapriya, N.; Fronczek, F.R.; Natarajan, K. New Ru(II)-dmso complexes with heterocyclic hydrazone ligands towards cancer chemotherapy. Polyhedron, 2008, 27, 1917-1924.
[13]
Jayanthi, E.; Kalaiselvi, S.; Padma, V.V.; Bhuvanesh, N.S.P.; Dharmaraj, N. Synthesis, characterization, DNA/protein binding and in vitro cytotoxic evaluation of new Ru(III) complexes containing aroylhydrazone ligands: Does hydrogen bonding influence the coordination behavior of hydrazones? Inorg. Chim. Acta, 2015, 429, 148-159.
[14]
Hosseini-Monfared, H.; Bikas, R.; Mahboubi-Anarjan, P.; Blake, A.J.; Lippolis, V.; Arslan, N.B.; Kazak, C. Oxidovanadium(V) complexes containing hydrazone based O,N,O-donor ligands: Synthesis, structure, catalytic properties and theoretical calculations. Polyhedron, 2014, 69, 90-102.
[15]
Ulukaya, E.; Ari, F.; Dimas, K.; Ikitimur, E.I.; Guney, E.; Yilmaz, V.T. Anti-cancer activity of a novel palladium(II) complex on human breast cancer cells in vitro and in vivo. Eur. J. Med. Chem., 2011, 46, 4957-4963.
[16]
Sathyadevi, P.; Krishnamoorthy, P.; Alagesan, M.; Thanigaimani, K.; Thomas, M.P.; Dharmaraj, N. Synthesis, crystal structure, electrochemistry and studies on protein binding, antioxidant and biocidal activities of Ni(II) and Co(II) hydrazone complexes. Polyhedron, 2012, 31, 294-306.
[17]
Mohareb, R.M.; Al-Omran, F. Reaction of pregnenolone with cyanoacetylhydrazine: Novel synthesis of hydrazide-hydrazone, pyrazole, pyridine, thiazole, thiophene derivatives and their cytotoxicity evaluations. Steroids, 2012, 77, 1551-1559.
[18]
Zining, C.; Ying, L.; Yun, L.; Juan, H.; Jingrong, C.; Ruiqing, W.; Xinling, Y. New class of potent antitumor acylhydrazone derivatives containing furan. Eur. J. Med. Chem., 2010, 45, 5576-5584.
[19]
Altıntop, M.D.; Özdemir, A.; Turan-Zitouni, G.; Ilgın, S.; Atlı, Ö.; İşcan, G.; Kaplancıklı, Z.A. Synthesis and biological evaluation of some hydrazone derivatives as new anticandidal and anticancer agents. Eur. J. Med. Chem., 2012, 58, 299-307.
[20]
Kocyigit-Kaymakcioglu, B.; Oruc-Emre, E.E.; Unsalan, S.; Rollas, S. Antituberculosis activity of hydrazones derived from 4-fluorobenzoic acid hydrazide. Med. Chem. Res., 2009, 18, 277-286.
[21]
Krishnamoorthy, P.; Sathyadevi, P.; Cowley, A.H.; Butorac, R.R.; Dhamaraj, N. Evaluation of DNA binding, DNA cleavage, protein binding and in vitro cytotoxic activities of bivalent transition metal hydrazone complexes. Eur. J. Med. Chem., 2011, 46, 3376-3387.
[22]
Dikmen, M.; Ozturk, N.; Ozturk, Y. The antioxidant potency of punica granatum L. fruit peel reduces cell proliferation and induces apoptosis on breast cancer. J. Med. Food, 2011, 14, 1638-1646.
[23]
Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 1993, 65, 55-63.
[24]
Bird, C.; Kirstein, S. Real-time, label-free monitoring of cellular invasion and migration with the xCELLigence system. App. Note Nat. Methods, 2009, 6, 622.
[25]
Solly, K.; Wang, X.; Xu, X.; Strulovici, B.; Zheng, W. Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays. Assay Drug Dev. Technol., 2004, 2, 363-372.
[26]
Urcan, E.; Haertel, U.; Styllou, M.; Hickel, R.; Scherthan, H.; Reichl, F.X. Real-time xCELLigence impedance analysis of the cytotoxicity of dental composite components on human gingival fibroblasts. Dent. Mater., 2010, 26, 51-58.
[27]
Ozkay, Y.; Yurttas, L.; Dikmen, M.; Engür, S. Synthesis and antiproliferative activity evaluation of new thiazole-benzimidazole derivatives using real-time cell analysis (RTCA DP). Med. Chem. Res., 2016, 25, 482-493.
[28]
Dikmen, M.; Cantürk, Z.; Engür, S.; Demirtaş, B.; İlhan, S. Antiangiogenic and antiproliferative effects of halotolerant Penicillium chrysogenum var. chrysogenum on the human umblical vein endothelial cells(HUVECs), IEEE, Xplore. Digital Lib., 2013, 4, 1-4.
[29]
Lee, E.; Koskimaki, J.E.; Pandey, N.B.; Popel, A.S. Inhibition of lymphangiogenesis and angiogenesis in breast tumor xenografts and lymph nodes by a peptide derived from transmembrane protein. Neoplasia, 2013, 15, 112-124.
[30]
Eisenberg, M.C.; Yangjin, K.; Li, R.; Ackerman, W.E.; Kniss, D.A.; Friedman, A. Mechanistic modeling of the effects of myoferlin on tumor cell invasion. Proc. Natl. Acad. Sci., 2011, 108, 20078-20083.
[31]
Liu, W.Y.; Li, H.Y.; Zhao, B.X.; Shin, D.S.; Lian, S.; Miao, J.Y. Synthesis of novel ribavirin hydrazone derivatives and anti-proliferative activity against A549 lung cancer cells. Carbohydr. Res., 2009, 344, 1270-1275.
[32]
Liu, M.; Wang, Y.; Wangyang, W.Z.; Liu, F.; Cui, Y.L.; Duan, Y.S.; Wang, M.; Liu, S.Z.; Rui, C.H. Design, synthesis and insecticidal activities of phtalimides containing a hydrazone substructure. J. Agric. Food Chem., 2010, 58, 6858-6863.
[33]
Ozdemir, Ü.Ö.; Akkaya, N.; Özbek, N. New nickel(II), palladium(II), platinum(II) complexes with aromatic methanesulfonylhydrazone based ligands. Synthesis, spectroscopic characterization and in vitro antibacterial evaluation. Inorg. Chim. Acta, 2013, 400, 13-19.
[34]
Naik, V.M.; Mallur, N.B. Synthesis and characterization of niobium(V) complexes with terdentate ONO donor hydrazones. Indian J. Chem., 2002, 41A, 780-784.
[35]
Jing-lin, W.; Ya-qin, Z.; Bin-sheng, Y. Transition metal complexes of asymmetrical aroyl-hydrazone ligand: Syntheses, structures, DNA binding and cleavage studies. Inorg. Chim. Acta, 2014, 409, 484-496.
[36]
Galal, S.A.; Hegab, K.H.; Kassab, A.S.; Rodriguez, M.L.; Kerwin, S.M.; El-Khamry, A.A.; El Diwani, H.I. New transition metal ion complexes with benzimidazole-5-carboxylic acid hydrazides with antitumor activity. Eur. J. Med. Chem., 2009, 44, 1500-1508.
[37]
Galic, N.; Rubcic, M.; Magdic, ´.K.; Cindric, ´.M.; Tomišic, V. Solution and solid-state studies of complexation of transition-metal cations and Al(III) by aroylhydrazones derived from nicotinic acid hydrazide. Inorg. Chim. Acta, 2011, 366, 98-104.
[38]
Sönmez, M.; Hacıyusufoğlu, M.E. Synthesis, characterization and antimicrobial studies of Cu(II), Co(II), Ni(II) and Zn(II) Schiff base complexes derived from acetylacetone with 1-amino-5-benzoyl-4-phenyl-1H-pyrimidine-2-one. Asian J. Chem., 2006, 18, 2032-2036.
[39]
McCauley, J.; Zivanovic, A.; Skropeta, D. Bioassays for anticancer activities. Methods Mol. Biol., 2013, 1055, 191-205.
[40]
Martinez-Serra, J.; Gutierrez, A.; Muñoz-Capó, S.; Navarro-Palou, M.; Ros, T.; Amat, J.C.; Lopez, B.; Marcus, T.F.; Fueyo, L.; Suquia, A.G.; Gines, J.; Rubio, F.; Ramos, R.; Besalduch, J. xCELLigence system for real-time label-free monitoring of growth and viability of cell lines from hematological malignancies. OncoTargets Ther., 2014, 7, 985-994.
[41]
Moniri, M.R.; Young, A.; Reinheimer, K.; Rayat, J.; Dai, L.J.; Warnock, G.L. Dynamic assessment of cell viability, proliferation and migration using real time cell analyzer system (RTCA). Cytotechnology, 2015, 67, 379-386.
Article Metrics
40
3
1
2